The Burst Enhancement of MRI Using Magnetic Resonance Tuning Based Contrast Agents

Magnetic resonance imaging (MRI) contrast agents face persistent challenges in achieving target-specific activation and high signal-to-noise ratios (SNRs). To address these limitations, we developed LP-GZF, a bioresponsive nanoprobe leveraging magnetic resonance tuning (MRET) within tumor-targeting liposomes. The system coencapsulates Gd-DOTA (paramagnetic enhancer) and Zn0.4Fe2.6O4@DMSA (superparamagnetic quencher), engineered to switch between “OFF” and “ON” states via spatial separation. It has also been confirmed that the relaxivity of LP-GZF is only related to its state, instead of its concentration. In the native state, the proximity between components suppresses Gd3+ relaxivity (0.15 mM–1 s–1), while the release of Gd-DOTA restores relaxivity to 4.25 mM–1 s–1, a 28.3-fold enhancement. In 4T1 tumor-bearing mice, LP-GZF demonstrated delayed burst-enhancement kinetics, with SNR surging from 29.00 ± 1.13 to 48.88 ± 3.32 at 2 h postinjection, clearly lighting the boundary of tumor tissue. The outstanding performance of LP-GZF is attributed to the selective enrichment in the tumor and the subsequent spatial separation of the “enhancer” and “quencher”. The nanoprobe exhibited excellent biocompatibility and hepatorenal clearance. This work establishes a paradigm for stimuli-responsive contrast agents, combining spatiotemporal precision with analytical reliability for early cancer diagnosis.